Do comorbidities and fragility predict outcomes in ambulatory patients with HFmrEF?
Comorbidities and fragility independently predict outcomes in HFmrEF and should be part of routine clinical assessment.
Comorbidities and fragility are independent predictors of outcomes in ambulatory patients with HFmrHF and should be considered in the routine clinical assessment of HFmrEF.
Gastelurrutia et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: